STRATUS, a Phase II Study of Abituzumab in Patients with Systemic Sclerosis-associated Interstitial Lung Disease.

CONCLUSION: Further investigation of abituzumab for treatment of SSc-ILD is required.
PMID: 33004536 [PubMed - as supplied by publisher]

Source: Journal of Rheumatology - October 3, 2020 Category: Rheumatology Tags: J Rheumatol Source Type: research